Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

30

Revenue 2017

Botox/Neuromodulator

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Botox/Neuromodulator was produced by Allergan.

Actavis 'considering' white knight bid for Allergan

Actavis 'considering' white knight bid for Allergan Allergan, the marketers of Botox among other healthcare and aesthetic products, has been the target of an unwanted takeover bid from Canada's Valeant since April this year.

Valeant dangles higher bid in front of Allergan shareholders

Valeant dangles higher bid in front of Allergan shareholders Botox manufacturer's management as "simply a tactic to distract investors from Allergan's outstanding third quarter results.".

Valeant adds Jeffrey Ubben to board

Valeant adds Jeffrey Ubben to board Ubben joins at a crucial time for Valeant as the company tries to take over Allergan, the marketer of Botox and other aesthetic and health products.

Allergan agrees to shareholder meeting on Valeant bid

Allergan agrees to shareholder meeting on Valeant bid The Botox manufacturer has been forced to go ahead with organising the meeting after major shareholder Pershing Square Capital, which is supporting Valeant's bid, managed to convince 31 per cent

Valeant extends Allergan bid deadline to end of 2014

Valeant extends Allergan bid deadline to end of 2014 Valeant had initially given Botox makers Allergan a deadline of August 15, 2014, to make a decision on its $53bn offer, which was proposed in June.

[ Previous 5 results ] 6 7 8 9 10 11 12 13 14 15 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
EPG Health

REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics